Lung Cancer Management in North Carolina: Updates for 2020 - LIVE
Shetal Patel, MD, PhD, from the UNC Lineberger Thoracic Oncology group will describe relevant updates in systemic therapy for lung cancers for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
These courses are intended for medical, radiation, and surgical oncologists, hematologists, advanced practice nurses, physician assistants, radiologic technologists, researchers, pharmacists, trainees, and others who are interested in care of patients with cancer in North Carolina.
Recognize biomarkers for targeted therapy selection for patients with non-small cell lung cancer
Compare immune checkpoint inhibitor treatment options for metastatic non-small cell lung cancer
Describe the role of immune checkpoint inhibitors in small cell lung cancer
Shetal A. Patel, MD, PhD
Presenter Disclosure Information
Shetal A. Patel, MD, PhD, receives research support from AstraZeneca and has no other relevant financial relationships with commercial interests as defined by the ACCME.
The Greensboro Area Health Education Center is approved as a provider of nursing continuing professional development by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
Approved by the UNC Eshelman School of Pharmacy for ACPE.
Approved by the American Society of Radiologic Technologists (ASRT).
The UNC School of Medicine of The University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The School of Medicine of The University of North Carolina at Chapel Hill designates this activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation